Oxford Biomedica (OXBDF) News Today $5.65 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Oxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorganOctober 29, 2024 | markets.businessinsider.comOxford Biomedica Seeks Stock Market ExpansionOctober 22, 2024 | markets.businessinsider.comShort Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Drops By 66.7%Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totalling 100 shares, a decrease of 66.7% from the September 15th total of 300 shares. Based on an average daily trading volume, of 5,600 shares, the short-interest ratio is currently 0.0 days.October 10, 2024 | marketbeat.comRBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)September 27, 2024 | markets.businessinsider.comOxford BioMedica: A Strong Buy on Undervaluation and Promising Growth ProspectsSeptember 24, 2024 | markets.businessinsider.comOxford Biomedica posts strong revenue growth in first half resultsSeptember 23, 2024 | msn.comOxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMOSeptember 18, 2024 | globenewswire.comLucinda Crabtree joins Oxford Biomedica as Chief Financial Officer todaySeptember 2, 2024 | globenewswire.comOxford Biomedica plc (OXBDF)August 18, 2024 | finance.yahoo.comOxford Biomedica – Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | markets.businessinsider.comOxford Biomedica announces CFO transitionJuly 17, 2024 | globenewswire.comOxford Biomedica Full Year 2023 Earnings: Misses ExpectationsMay 1, 2024 | finance.yahoo.comOxford Biomedica plc GAAP EPS of -163.11p, revenue of £89.5MApril 30, 2024 | msn.comSMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumpsApril 29, 2024 | lse.co.ukOxford BioMedica PLCApril 20, 2024 | barrons.comOxford Biomedica Insiders Placed Bullish Bets Worth UK£415.3kMarch 30, 2024 | finance.yahoo.comOxford BioMedica PLC (OXB)January 23, 2024 | investing.comOxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturingJanuary 23, 2024 | finance.yahoo.comOxford BioMedica PLC OXOANovember 5, 2023 | morningstar.comAnalysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS NumbersSeptember 25, 2023 | finance.yahoo.comOxford Biomedica (OTCMKTS:OXBDF) Price Target Cut to GBX 325 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. cut their price objective on Oxford Biomedica from GBX 495 ($6.13) to GBX 325 ($4.03) in a research report on Friday.September 22, 2023 | marketbeat.comOxford BioMedica shares boom as manufacturer expands complex cancer therapiesSeptember 21, 2023 | msn.comOxford BioMedica shares up, in talks to buy ABL Europe but loss widensSeptember 20, 2023 | lse.co.ukOxford Biomedica stock soars on rosy forecast, talks to buy ABL EuropeSeptember 20, 2023 | msn.comOxford BioMedica Shares Rise on Transformational Deal Talks, Revenue Growth ExpectationSeptember 20, 2023 | marketwatch.comOxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformationSeptember 20, 2023 | finance.yahoo.comKyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® PlatformSeptember 20, 2023 | finance.yahoo.comOxford Biomedica to host webinar showcasing the TetraVecta™ systemSeptember 7, 2023 | finance.yahoo.comOxford Biomedica (LON:OXB) shareholders have endured a 50% loss from investing in the stock five years agoJuly 10, 2023 | finance.yahoo.comOxford BioMedica's Executive Pay Report Gets Low Shareholder Support at Annual MeetingJune 23, 2023 | marketwatch.comDr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023February 20, 2023 | finance.yahoo.comThe past year for Oxford Biomedica (LON:OXB) investors has not been profitableJanuary 30, 2023 | finance.yahoo.comOxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 millionNovember 14, 2022 | finance.yahoo.comOxford BioMedica swings to interim loss as costs climb, revenue fallsSeptember 15, 2022 | lse.co.ukOxford Biomedica (LON:OXB) shareholders have endured a 66% loss from investing in the stock a year agoAugust 19, 2022 | finance.yahoo.comOxford BioMedica begins new project and signs license agreementJuly 26, 2022 | lse.co.ukOxford Biomedica Signs Licence & Supply Agreement with New Partner for LentiVector® Platform for CAR-T TherapyJuly 26, 2022 | finance.yahoo.comOxford Biomedica plc's (LON:OXB) Intrinsic Value Is Potentially 20% Below Its Share PriceJuly 16, 2022 | finance.yahoo.comSMALL-CAP WINNERS & LOSERS: Oxford BioMedica rises on AstraZeneca dealJuly 1, 2022 | lse.co.ukAstraZeneca signs new three-year deal with Oxford Biomedica for COVID shotJuly 1, 2022 | seekingalpha.comOxford BioMedica extends Covid vaccine deal with AstraZenecaJuly 1, 2022 | finance.yahoo.comUS FDA lifts clinical hold on Oxford BioMedica partner's trialJune 14, 2022 | lse.co.ukCould The Market Be Wrong About Oxford Biomedica plc (LON:OXB) Given Its Attractive Financial Prospects?May 15, 2022 | finance.yahoo.comOxford Biomedica reports 63% revenue growth linked to AstraZeneca vaccine supply: PrelimApril 20, 2022 | seekingalpha.comOxford BioMedica shares fall as warns on 2022 amid Covid jab pauseApril 20, 2022 | lse.co.ukOxford BioMedica Sees Lower 2022 Revenue on Suspension of Covid-19 Vaccine With AstraZenecaApril 20, 2022 | marketwatch.comOxford BioMedica warns revenue will be hit by AstraZeneca jab uncertaintyApril 20, 2022 | ft.comOxford Biomedica warns on sales after pausing AstraZeneca COVID vaccineApril 20, 2022 | uk.finance.yahoo.comOxford Biomedica Preliminary ResultsApril 20, 2022 | finance.yahoo.comOxford Biomedica completes deal with Homology Medicines to set up 1st US subsidiaryMarch 13, 2022 | seekingalpha.com Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! OXBDF Media Mentions By Week OXBDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXBDF News Sentiment▼0.000.46▲Average Medical News Sentiment OXBDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXBDF Articles This Week▼10▲OXBDF Articles Average Week Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies THKLY News KNCAY News APELY News TYEKF News ERO News PALAF News MXCHY News DPMLF News BCHEY News CSIOY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OXBDF) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredHarris Pushes Radical Tax Hikes, Digital Currency—Your Money at Risk!First they attempted to silence Trump with a blatant attack. Now Joe Biden, the puppet president, has stepp...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
